-
公开(公告)号:US20180370987A1
公开(公告)日:2018-12-27
申请号:US16046382
申请日:2018-07-26
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D401/06 , C07D211/34 , C07D403/06 , C07D471/04 , C07D263/32 , C07D231/12 , C07D277/593 , C07D261/08
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US20180208606A1
公开(公告)日:2018-07-26
申请号:US15860741
申请日:2018-01-03
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D401/06 , C07D471/08 , C07D231/12 , C07D471/04 , C07D403/10 , C07D211/78 , C07D451/02 , C07D277/30 , C07D205/06 , C07D305/10 , C07D211/70 , C07D277/34 , C07D263/32 , C07D261/08 , C07D403/06
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US09908899B2
公开(公告)日:2018-03-06
申请号:US15337354
申请日:2016-10-28
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: A61K31/397 , A61K31/46 , A61K31/4427 , A61K31/445 , A61K31/337 , C07D513/04 , C07D263/32 , C07D471/04 , C07D231/12 , C07D261/08 , C07D211/70 , C07D403/10 , C07D403/06 , C07D211/78 , C07D451/02 , C07D305/10 , C07D205/06 , C07D401/06 , C07D471/08 , C07D277/34 , C07D277/30
CPC classification number: C07D513/04 , C07D205/06 , C07D211/70 , C07D211/78 , C07D231/12 , C07D261/08 , C07D263/32 , C07D277/30 , C07D277/34 , C07D305/10 , C07D401/06 , C07D403/06 , C07D403/10 , C07D451/02 , C07D471/04 , C07D471/08
Abstract: The compounds provided herein are phenyl analine amides and are useful for inhibiting histone deacteylase (“HDAC”) enzymes, such as HDAC1, HDAC2, and HDAC3.
-
公开(公告)号:US20190233439A1
公开(公告)日:2019-08-01
申请号:US16299423
申请日:2019-03-12
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D277/30 , C07D401/06 , C07D211/34 , C07D403/06 , C07D277/593 , C07D261/08 , C07D263/32 , C07D231/12 , C07D471/04
CPC classification number: C07D513/04 , C07D211/34 , C07D231/12 , C07D261/08 , C07D263/32 , C07D277/30 , C07D277/593 , C07D401/06 , C07D403/06 , C07D471/04
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US09512143B2
公开(公告)日:2016-12-06
申请号:US14598583
申请日:2015-01-16
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: A61K31/337 , A01N37/18 , C07D205/06 , A61K31/439 , A61K31/44 , A61K31/445 , C07D211/70 , C07D213/90 , C07D305/10 , C07D513/04 , C07D471/04 , C07D231/12 , C07D403/06 , C07D401/06 , C07D471/08 , C07D261/08 , C07D263/32 , C07D277/34 , C07D277/30 , C07D451/02
CPC classification number: C07D513/04 , C07D205/06 , C07D211/70 , C07D211/78 , C07D231/12 , C07D261/08 , C07D263/32 , C07D277/30 , C07D277/34 , C07D305/10 , C07D401/06 , C07D403/06 , C07D403/10 , C07D451/02 , C07D471/04 , C07D471/08
Abstract: The compounds provided herein are phenyl analine amides and are useful for inhibiting histone deacteylase (“HDAC”) enzymes, such as HDAC1, HDAC2, and HDAC3.
Abstract translation: 本文提供的化合物是苯基分解酰胺,并且可用于抑制组蛋白失活酶(“HDAC”)酶,例如HDAC1,HDAC2和HDAC3。
-
公开(公告)号:US10526346B2
公开(公告)日:2020-01-07
申请号:US15860741
申请日:2018-01-03
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: A61K31/397 , A61K31/445 , A61K31/44 , A61K31/439 , A61K31/337 , C07D513/04 , C07D471/04 , C07D231/12 , C07D403/06 , C07D401/06 , C07D471/08 , C07D261/08 , C07D263/32 , C07D277/34 , C07D211/70 , C07D305/10 , C07D205/06 , C07D277/30 , C07D451/02 , C07D211/78 , C07D403/10
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US10059723B2
公开(公告)日:2018-08-28
申请号:US15346877
申请日:2016-11-09
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D277/593 , C07D231/12 , C07D263/32 , C07D261/08 , C07D471/04 , C07D403/06 , C07D211/34 , C07D401/06
CPC classification number: C07D513/04 , C07D211/34 , C07D231/12 , C07D261/08 , C07D263/32 , C07D277/30 , C07D277/593 , C07D401/06 , C07D403/06 , C07D471/04
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US20170044186A1
公开(公告)日:2017-02-16
申请号:US15337354
申请日:2016-10-28
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D471/04 , C07D277/30 , C07D231/12 , C07D261/08 , C07D211/70 , C07D401/06 , C07D403/06 , C07D211/78 , C07D451/02 , C07D305/10 , C07D205/06 , C07D403/10 , C07D263/32
CPC classification number: C07D513/04 , C07D205/06 , C07D211/70 , C07D211/78 , C07D231/12 , C07D261/08 , C07D263/32 , C07D277/30 , C07D277/34 , C07D305/10 , C07D401/06 , C07D403/06 , C07D403/10 , C07D451/02 , C07D471/04 , C07D471/08
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US10981933B2
公开(公告)日:2021-04-20
申请号:US16299423
申请日:2019-03-12
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D277/593 , C07D231/12 , C07D263/32 , C07D261/08 , C07D471/04 , C07D403/06 , C07D211/34 , C07D401/06 , C07D277/30
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
公开(公告)号:US20200148704A1
公开(公告)日:2020-05-14
申请号:US16677954
申请日:2019-11-08
Applicant: BIOMARIN PHARMACEUTICAL INC.
Inventor: Vincent Jacques , James R. Rusche , Norton P. Peet , Jasbir Singh
IPC: C07D513/04 , C07D471/04 , C07D231/12 , C07D403/06 , C07D401/06 , C07D205/06 , C07D471/08 , C07D261/08 , C07D263/32 , C07D277/34 , C07D211/70 , C07D305/10 , C07D277/30 , C07D451/02 , C07D211/78 , C07D403/10
Abstract: This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
-
-
-
-
-
-
-
-
-